Functional roles of N‐glycans in cell signaling and cell adhesion in cancer

Glycosylation is one of the most common post‐translational modification reactions and nearly half of all known proteins in eukaryotes are glycosylated. In fact, changes in oligosaccharide structures are associated with many physiological and pathological events, including cell growth, migration, differentiation, tumor invasion, host–pathogen interactions, cell trafficking, and transmembrane signaling. Emerging roles of glycan functions have been highly attractive to scientists in various fields of life science as they open a field, “Functional Glycomics”, that is a comprehensive study of the glycan structures in relation to functions. In particular, the N‐glycans of signaling molecules including receptors or adhesion molecules are considered to be involved in cellular functions. This review will focus on the roles of glycosyltransferases involved in the biosynthesis of N‐glycan branching and identification of cell surface receptors as their target proteins. We also suggest that the modulation of N‐glycans of those receptors alters their important functions such as cell signaling and cell adhesion which are implicated in cancer invasion and metastasis. (Cancer Sci 2008; 99: 1304–1310)

[1]  D. Osumi,et al.  The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion. , 2007, Cancer research.

[2]  Y. Matsuzawa,et al.  Aberrant Glycosylation of E-cadherin Enhances Cell-Cell Binding to Suppress Metastasis* , 1996, The Journal of Biological Chemistry.

[3]  S. Akiyama,et al.  Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. , 2002, Cancer research.

[4]  R. Brentani,et al.  Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Naoyuki Taniguchi,et al.  Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. , 2006, Journal of biochemistry.

[6]  K. Katagiri,et al.  Occurrence of Oligosialic Acids on Integrin α5Subunit and Their Involvement in Cell Adhesion to Fibronectin* , 2001, The Journal of Biological Chemistry.

[7]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[8]  A. Amoresano,et al.  Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression. , 2003, Biochimica et biophysica acta.

[9]  C. Bertozzi,et al.  Chemical and biological strategies for engineering cell surface glycosylation. , 2001, Annual review of cell and developmental biology.

[10]  K. Sekiguchi,et al.  Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. , 2004, The Journal of biological chemistry.

[11]  K. Yamada,et al.  Analysis of the role of glycosylation of the human fibronectin receptor. , 1989, The Journal of biological chemistry.

[12]  M. Pierce,et al.  Deletion of Mouse Embryo Fibroblast N-Acetylglucosaminyltransferase V Stimulates α5β1 Integrin Expression Mediated by the Protein Kinase C Signaling Pathway* , 2005, Journal of Biological Chemistry.

[13]  H. Narimatsu Human glycogene cloning: focus on β3-glycosyltransferase and β4-glycosyltransferase families , 2006 .

[14]  N. Hayashi,et al.  N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. , 1993, Cancer research.

[15]  Naoyuki Taniguchi,et al.  Addition of beta1-6 GlcNAc branching to the oligosaccharide attached to Asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. , 2003, Glycobiology.

[16]  Naoyuki Taniguchi,et al.  Purification and cDNA Cloning of Porcine Brain GDP-L-Fuc:N-Acetyl-β-D-Glucosaminide α1→6Fucosyltransferase* , 1996, The Journal of Biological Chemistry.

[17]  H. Gabius,et al.  Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes* , 2004, Journal of Biological Chemistry.

[18]  N. Taniguchi,et al.  A secreted type of beta 1,6-N-acetylglucosaminyltransferase V (GnT-V) induces tumor angiogenesis without mediation of glycosylation: a novel function of GnT-V distinct from the original glycosyltransferase activity. , 2002, The Journal of biological chemistry.

[19]  S. Nakahara,et al.  Prometastatic Effect ofN-Acetylglucosaminyltransferase V Is Due to Modification and Stabilization of Active Matriptase by Adding β1–6 GlcNAc Branching* , 2002, The Journal of Biological Chemistry.

[20]  J. Gu,et al.  High expression of N‐acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis , 2006, FEBS letters.

[21]  J. Gutkind,et al.  Signaling from E-cadherins to the MAPK Pathway by the Recruitment and Activation of Epidermal Growth Factor Receptors upon Cell-Cell Contact Formation* , 2000, The Journal of Biological Chemistry.

[22]  J. Gu,et al.  Purification and characterization of UDP-N-acetylglucosamine: alpha-6-D-mannoside beta 1-6N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase V) from a human lung cancer cell line. , 1993, Journal of biochemistry.

[23]  S. Hakomori,et al.  Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. , 1994, The Journal of biological chemistry.

[24]  N. Taniguchi,et al.  Overexpression of N-Acetylglucosaminyltransferase III Enhances the Epidermal Growth Factor-induced Phosphorylation of ERK in HeLaS3 Cells by Up-regulation of the Internalization Rate of the Receptors* , 2001, The Journal of Biological Chemistry.

[25]  K. Sekiguchi,et al.  Introduction of Bisecting GlcNAc into Integrin α5β1 Reduces Ligand Binding and Down-regulates Cell Adhesion and Cell Migration* , 2004, Journal of Biological Chemistry.

[26]  P. Seeburg,et al.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.

[27]  J. Gu,et al.  Functional glycomics and evidence for gain- and loss-of-functions of target proteins for glycosyltransferases involved in N-glycan biosynthesis: their pivotal roles in growth and development, cancer metastasis and antibody therapy against cancer , 2004, Proceedings of the Japan Academy. Series B, Physical and Biological Sciences.

[28]  Y. Matsuzawa,et al.  The Addition of Bisecting N-Acetylglucosamine Residues to E-cadherin Down-regulates the Tyrosine Phosphorylation of β-Catenin* , 2001, The Journal of Biological Chemistry.

[29]  James E. Bailey,et al.  Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.

[30]  R. Cummings,et al.  A mouse lymphoma cell line resistant to the leukoagglutinating lectin from Phaseolus vulgaris is deficient in UDP-GlcNAc: alpha-D-mannoside beta 1,6 N-acetylglucosaminyltransferase. , 1982, The Journal of biological chemistry.

[31]  J. Gu,et al.  Beta1,4-N-Acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. , 2003, Glycobiology.

[32]  T. Yoshimura,et al.  Characterization of cis-Acting Elements of the Gene for Macrophage-stimulating Protein from the Human , 1996, The Journal of Biological Chemistry.

[33]  N. Taniguchi,et al.  Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Grivet Évolution et aspect actuel du microscope électronique: Le congrès international de microscopie électronique, Paris, 14–22 September 1950 , 1951 .

[35]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[36]  N. Taniguchi,et al.  Purification, cDNA cloning, and expression of UDP-N-acetylglucosamine: beta-D-mannoside beta-1,4N-acetylglucosaminyltransferase III from rat kidney. , 1992, The Journal of biological chemistry.

[37]  G. Carpenter,et al.  Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. , 1984, The Journal of biological chemistry.

[38]  R. Dwek Glycobiology: "towards understanding the function of sugars". , 1996, Biochemical Society transactions.

[39]  J. Dennis,et al.  Suppression of tumor growth and metastasis in Mgat5-deficient mice , 2000, Nature Medicine.

[40]  K. Segawa,et al.  Increased expression of highly branched N-glycans at cell surface is correlated with the malignant phenotypes of mouse tumor cells. , 1997, Cancer research.

[41]  J. Dennis,et al.  Complex N-Glycan Number and Degree of Branching Cooperate to Regulate Cell Proliferation and Differentiation , 2007, Cell.

[42]  J. Dennis,et al.  Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis. , 1991, The Journal of biological chemistry.

[43]  J. Dennis,et al.  Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V , 1995, The Journal of cell biology.

[44]  N. Taniguchi,et al.  Gene Transfection-mediated Overexpression of β1,4-N-Acetylglucosamine Bisecting Oligosaccharides in Glioma Cell Line U373 MG Inhibits Epidermal Growth Factor Receptor Function* , 1997, The Journal of Biological Chemistry.

[45]  A. Amoresano,et al.  Glycosylation profile of integrin α3β1 changes with melanoma progression , 2003 .

[46]  Naoyuki Taniguchi,et al.  Core Fucosylation Regulates Epidermal Growth Factor Receptor-mediated Intracellular Signaling* , 2006, Journal of Biological Chemistry.

[47]  Amos Etzioni,et al.  Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency , 2001, Nature Genetics.

[48]  A. Kobata,et al.  Altered glycosylation of β1 integrins associated with reduced adhesiveness to fibronectin and laminin , 1993, International journal of cancer.

[49]  S. Akiyama,et al.  Aberrant N-Glycosylation of β1 Integrin Causes Reduced α5β1 Integrin Clustering and Stimulates Cell Migration , 2002 .

[50]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[51]  Naoyuki Taniguchi,et al.  Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Rita Gerardy-Schahn,et al.  The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter , 2001, Nature Genetics.

[53]  Y. Ikeda,et al.  The alpha1-6-fucosyltransferase gene and its biological significance. , 1999, Biochimica et biophysica acta.

[54]  M. Mihara,et al.  Overexpression of N-Acetylglucosaminyltransferase III Disrupts the Tyrosine Phosphorylation of Trk with Resultant Signaling Dysfunction in PC12 Cells Treated with Nerve Growth Factor* , 1997, The Journal of Biological Chemistry.

[55]  E. Eklund,et al.  Hyposialylation of Integrins Stimulates the Activity of Myeloid Fibronectin Receptors* , 2002, The Journal of Biological Chemistry.

[56]  A. Benguría,et al.  Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins , 1995, Molecular and Cellular Biochemistry.

[57]  J. Marth,et al.  Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. , 1997, Glycobiology.

[58]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[59]  J. Dennis,et al.  Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin , 1982, Nature.

[60]  H. Schachter Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. , 1986, Advances in experimental medicine and biology.

[61]  N. Niikawa,et al.  cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V+. , 1994, Biochemical and biophysical research communications.

[62]  J. Dennis,et al.  UDP-N-acetylglucosamine:α-6-d-mannoside β1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice , 2002 .

[63]  J. Dennis,et al.  Regulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis , 2004, Science.

[64]  Toshihiko Oka,et al.  Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. , 2002, Biochimica et biophysica acta.

[65]  N Taniguchi,et al.  Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. , 1997, Journal of biochemistry.

[66]  J. Dennis,et al.  UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice. , 2002, Biochimica et biophysica acta.

[67]  K. Katagiri,et al.  Occurrence of oligosialic acids on integrin alpha 5 subunit and their involvement in cell adhesion to fibronectin. , 2001, The Journal of biological chemistry.

[68]  J. Gu,et al.  beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells. , 2006, Glycobiology.

[69]  R. Hazan,et al.  Cadherin Switch in Tumor Progression , 2004, Annals of the New York Academy of Sciences.

[70]  S. Fujii,et al.  Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-->6fucosyltransferase. , 1996, The Journal of biological chemistry.

[71]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[72]  N. Taniguchi,et al.  Synthesis of a bisubstrate-type inhibitor of N-acetylglucosaminyltransferases. , 2004, Angewandte Chemie.

[73]  N. Niikawa,et al.  cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). , 1993, Journal of biochemistry.

[74]  M. Kuroki,et al.  Carbohydrate structures of nonspecific cross-reacting antigen-2, a glycoprotein purified from meconium as an antigen cross-reacting with anticarcinoembryonic antigen antibody. Occurrence of complex-type sugar chains with the Gal beta 1----3GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----outer chai , 1989, The Journal of biological chemistry.

[75]  Y. Ikeda,et al.  Role of N-glycans in growth factor signaling , 2003, Glycoconjugate Journal.

[76]  Eiji Miyoshi,et al.  The α1-6-fucosyltransferase gene and its biological significance , 1999 .

[77]  H. Narimatsu Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. , 2006, Current opinion in structural biology.

[78]  M. Pierce,et al.  Purification and characterization of rat kidney UDP-N-acetylglucosamine: alpha-6-D-mannoside beta-1,6-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.

[79]  D. Osumi,et al.  N-glycan of ErbB family plays a crucial role in dimer formation and tumor promotion. , 2008, Biochimica et biophysica acta.

[80]  Naoyuki Taniguchi,et al.  Decoding sugar functions by identifying target glycoproteins. , 2006, Current opinion in structural biology.

[81]  C. J. Stroop,et al.  Characterization of the carbohydrate chains of the secreted form of the human epidermal growth factor receptor. , 2000, Glycobiology.

[82]  Sean P. Palecek,et al.  Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness , 1997, Nature.

[83]  M. Barbacid,et al.  Nerve growth factor mediates signal transduction through trk homodimer receptors , 1992, Neuron.

[84]  V. Xue,et al.  Sialidase Treatment Exposes the βT1-Integrin Active Ligand Binding Site on HL60 Cells and Increases Binding to Fibronectin , 2000, Cell adhesion and communication.

[85]  S. Nagataki,et al.  Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. , 1993, The New England journal of medicine.

[86]  J. Dennis,et al.  Protein glycosylation in development and disease , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[87]  R. Kerbel,et al.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.

[88]  M. Takeichi,et al.  Cadherins: a molecular family important in selective cell-cell adhesion. , 1990, Annual review of biochemistry.

[89]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[90]  Y. Ikeda,et al.  The Asn-420-linked Sugar Chain in Human Epidermal Growth Factor Receptor Suppresses Ligand-independent Spontaneous Oligomerization , 2000, The Journal of Biological Chemistry.

[91]  M. Du,et al.  Fucosyltransferases: Differential plasma and tissue alterations in hepatocellular carcinoma and cirrhosis , 1991, Hepatology.